Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extraintestinal Pathogenic Escherichia Coli Prevention”

3 trials

Showing 3 of 3 results

Testing effectiveness (Phase 2)Study completedNCT03819049
What this trial is testing

Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

Who this might be right for
Extraintestinal Pathogenic Escherichia Coli Prevention
Janssen Research & Development, LLC 836
Large-scale testing (Phase 3)Study completedNCT06134804
What this trial is testing

9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older

Who this might be right for
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Janssen Research & Development, LLC 959
Large-scale testing (Phase 3)Study completedNCT04899336
What this trial is testing

Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years

Who this might be right for
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Janssen Research & Development, LLC 17,797

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation